| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |